Back to mobile site

Medtronic, Inc. (MDT) CEO/Investor Meetings Takeaways - Truist

March 18, 2021 6:59 AM EDT Send to a Friend
Truist Securities analyst Kaila Krum reiterated a Buy rating and $132.00 price target on Medtronic, Inc. (NYSE: MDT) after hosting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login